FDA Approved: NILOTINIB — Original Application (AvKARE)

View source ↗

Summary

FDA approved AvKARE's nilotinib original application, authorizing a generic version of nilotinib for leukemia indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

ORIG AP for NILOTINIB (NILOTINIB)